论文部分内容阅读
由于原料药出口仍在低谷中徘徊,加之国内原料药市场的不景气以及药价改革等诸多因素的影响,1998年药品市场将呈现出交易平淡,价格升少降多的情况。其主要特点有四: 从目前药品各厂家供货目录和交易情况看,我国医药存在的结构性矛盾仍十分突出,其制剂品种绝大多数供大于求,加之进口制剂的大量增加(1996年比1995年增长15.4%),加重了国内市场的压力。例如氨苄青霉素原料,1996年已产大于销,1997年上半年产量又比上年同期大幅增加,造成制剂货源过剩,价格降了又降。氨苄青霉素针0.5克每支降到0.58元左右;头孢氨苄胶囊
As the exports of APIs are still hovering in the trough, combined with the slump in the domestic API market and the reform of drug prices, the pharmaceutical market will show signs of a dull transaction and a drop in prices in 1998. Its main features are four: from the current drug manufacturers supply catalog and transaction conditions, the structural contradictions in China’s pharmaceutical is still very prominent, the vast majority of its preparation varieties oversupply, combined with the large increase in imported preparations (1996 than A 15.4% increase in 1995), adding to the pressure on the domestic market. For example, ampicillin raw materials have been produced in 1996 than in the first half of 1997, a substantial increase in production over the previous year, resulting in excess supply of preparations, the price dropped. Ampicillin 0.5 grams per needle dropped to about 0.58 yuan; cephalexin capsules